IGC PHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.1M | $35.9M | $14.5M |
| FY2022 | $2.9M | $26.8M | $10.5M |
| FY2023 | $2.3M | $17.2M | $3.2M |
| FY2024 | $2.6M | $9.9M | $1.2M |
| FY2025 | $2.4M | $8.7M | $405.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.1M | $35.9M | $14.5M |
| FY2022 | $2.9M | $26.8M | $10.5M |
| FY2023 | $2.3M | $17.2M | $3.2M |
| FY2024 | $2.6M | $9.9M | $1.2M |
| FY2025 | $2.4M | $8.7M | $405.0K |